The Classy Investors

  /  Top News   /  Stocks – Principia Biopharma, Tesla and Nvidia Rise Premarket

Stocks – Principia Biopharma, Tesla and Nvidia Rise Premarket




imageStock Markets13 hours ago (Aug 17, 2020 08:00AM ET)
image

(C) Reuters.

By Peter Nurse

Investing.com — Stocks in focus in premarket trade on Monday, August 17th. Please refresh for updates.

  • Principia Biopharma (NASDAQ:PRNB) stock rose 9.2% after French pharma giant Sanofi (NASDAQ:SNY) agreed to purchase the U.S. company in a deal that will be worth $3.7 billion. Sanofi is seen eyeing up the expansion of its autoimmune disease drug line.

  • Tesla (NASDAQ:TSLA) stock rose 1.5%, helped by investment firm Wedbush raising its price target to $1,900 from $1,800, citing continued signs of accelerating demand in China.

  • Nvidia (NASDAQ:NVDA) stock rose 1.9% after reports suggesting the U.S. chipmaker was in exclusive talks to buy U.K.-based chip designer Arm from private equity Japanese owner Softbank (OTC:SFTBY).

  • Amazon (NASDAQ:AMZN) stock rose 0.9% despite the tech giant being investigated by the German Federal Cartel Office for allegedly abusing its market position during the coronavirus pandemic.

  • Occidental Petroleum (NYSE:OXY) stock fell 1.5% after a regulatory filing Friday showed that Warren Buffett’s Berkshire Hathaway (NYSE:BRKa) sold its remaining stake in the second quarter.

  • Barrick Gold (NYSE:GOLD) stock rose 9.7% after a regulatory filing Friday showed Berkshire Hathaway acquired 20.9 million shares, worth $563 million in the three months to June.

  • Applied DNA Sciences (NASDAQ:APDN) rose 1.2% after applying for a new patent to help manufacture medicines that have the potential to address many diseases, including Covid-19.

  • Curevac (NASDAQ:CVAC) stock is likely to remain in demand after a sharp rise Friday following its listing on the Nasdaq exchange. The company, backed by the Gates Foundation among others, is working on a Covid-19 vaccine, and said Friday it expects to put it on the market by mid-2021.

  • JD.com (NASDAQ:JD) ADR rose 4.7% after strong quarterly results, as more customers used the Chinese retailer’s online platform to shop for groceries and other essentials in the face of the pandemic.

Stocks – Principia Biopharma, Tesla and Nvidia Rise Premarket

Disclaimer: Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. All CFDs (stocks, indexes, futures) and Forex prices are not provided by exchanges but rather by market makers, and so prices may not be accurate and may differ from the actual market price, meaning prices are indicative and not appropriate for trading purposes. Therefore Fusion Media doesn`t bear any responsibility for any trading losses you might incur as a result of using this data.

Fusion Media or anyone involved with Fusion Media will not accept any liability for loss or damage as a result of reliance on the information including data, quotes, charts and buy/sell signals contained within this website. Please be fully informed regarding the risks and costs associated with trading the financial markets, it is one of the riskiest investment forms possible.

image

Our Apps

DOWNLOAD APPApp store

Investing.com

(C) 2007-2020 Fusion Media Limited. All Rights Reserved

Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.

Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.

It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.